Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-13-046317)

Filing Details

Accession Number:: 0001140361-13-046317
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-16 16:47:00
Reporting Period:: 2013-12-12

Filing Date:: 2013-12-16
Accepted Time:: 2013-12-16 16:47:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1038684	J Robert Murray	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-12	500	$102.31	3,000	No	4	P	Indirect	by Spouse
Common Stock	Disposition	2013-12-12	8,383	$0.00	0	No	5	G	Indirect	by 2010 GRAT

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by Spouse
No	5	G	Indirect	by 2010 GRAT

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	24,228	Direct
Common Stock	10,526	Indirect	by 2012 GRAT

Footnotes

Reflects change in ownership of 7,337 shares from indirect through Grantor Retained Annunity Trust formed on 10/4/2010 (2010 GRAT) to direct, following 2010 GRAT annuity payment to the reporting person on 12/6/2013.
On 12/12/2013, 8,383 shares were transferred from the 2010 GRAT to an irrevocable family trust for the benefit of the reporting person's children.